Correlation Between ACADIA Pharmaceuticals and Intercept Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both ACADIA Pharmaceuticals and Intercept Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ACADIA Pharmaceuticals and Intercept Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ACADIA Pharmaceuticals and Intercept Pharmaceuticals, you can compare the effects of market volatilities on ACADIA Pharmaceuticals and Intercept Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ACADIA Pharmaceuticals with a short position of Intercept Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ACADIA Pharmaceuticals and Intercept Pharmaceuticals.
Diversification Opportunities for ACADIA Pharmaceuticals and Intercept Pharmaceuticals
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between ACADIA and Intercept is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding ACADIA Pharmaceuticals and Intercept Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intercept Pharmaceuticals and ACADIA Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ACADIA Pharmaceuticals are associated (or correlated) with Intercept Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intercept Pharmaceuticals has no effect on the direction of ACADIA Pharmaceuticals i.e., ACADIA Pharmaceuticals and Intercept Pharmaceuticals go up and down completely randomly.
Pair Corralation between ACADIA Pharmaceuticals and Intercept Pharmaceuticals
If you would invest 1,669 in ACADIA Pharmaceuticals on September 4, 2024 and sell it today you would lose (8.00) from holding ACADIA Pharmaceuticals or give up 0.48% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 1.56% |
Values | Daily Returns |
ACADIA Pharmaceuticals vs. Intercept Pharmaceuticals
Performance |
Timeline |
ACADIA Pharmaceuticals |
Intercept Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
ACADIA Pharmaceuticals and Intercept Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ACADIA Pharmaceuticals and Intercept Pharmaceuticals
The main advantage of trading using opposite ACADIA Pharmaceuticals and Intercept Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ACADIA Pharmaceuticals position performs unexpectedly, Intercept Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intercept Pharmaceuticals will offset losses from the drop in Intercept Pharmaceuticals' long position.ACADIA Pharmaceuticals vs. Madrigal Pharmaceuticals | ACADIA Pharmaceuticals vs. Viking Therapeutics | ACADIA Pharmaceuticals vs. Sarepta Therapeutics | ACADIA Pharmaceuticals vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |